Glenmark Gets USFDA Nod to Expand RYALTRIS Use
Glenmark touched a day’s high of Rs 2,249.30 on the NSE on Tuesday, after the USFDA approved a wider use of its allergy spray RYALTRIS....
Tag : Ryaltris
Glenmark Pharma Launches Ryaltris Nasal Spray for Allergic Rhinitis in US Market
US arm of Glenmark Pharmaceuticals has launched the fixed-dose combination (FDC) therapy for seasonal allergic rhinitis in the US market. This Ryaltris nasal spray will...
Glenmark Pharma submits drug application for Ryaltris with USFDA
Glenmark Pharmaceuticals has submitted a new drug application for its nasal spray Ryaltris, with the US health regulator. In a BSE filing the company stated,...